Navigation Links
MedeAnalytics Releases Analysis of Public Comments on ACO Proposed Rule
Date:6/13/2011

EMERYVILLE, Calif., June 13, 2011 /PRNewswire/ -- MedeAnalytics, a leading provider of healthcare performance management solutions, disseminated today a report which analyzes the leading healthcare constituencies' recommendations on the major factors of the accountable care organization (ACO) economic model as presented in the proposed rule for the Medicare Shared Savings Program.

(Logo:  http://photos.prnewswire.com/prnh/20100621/SF23660LOGO)

The proposed rule was released on March 31, 2011, and the public comment period ended on June 6, 2011. The MedeAnalytics report identifies nine elements of the program that function as the primary drivers of the Medicare ACO business model. In addition, it presents the respective positions on these elements of seven nationally recognized healthcare constituencies: the American Hospital Association, the Federation of American Hospitals, the American Medical Association, the American Medical Group Association, the Medical Group Management Association, America's Health Insurance Plans, and Brookings-Dartmouth.

"While there has been some rhetoric in the media about scrapping the entire ACO program as laid out by the proposed rule, the seven constituent organizations presented recommendations to revise, not repeal, the program," commented Ken Perez, who directs MedeAnalytics' healthcare policy team and serves as the company's senior vice president of marketing.

All seven organizations recommended a significant reduction to the 65 quality measures in the proposed rule (with the 32 measures of the Physician Group Practice Demonstration often cited as a preferred measure set), as well as a gradual phase-in period. A majority of the organizations urged the Centers for Medicare & Medicaid Services (CMS) to make the financial terms of the ACO program more attractive, with calls for a standard, flat Minimum Savings Rate, increases to the maximum shared savings rate, the elimination of withholding of a portion of the earned performance payment by CMS, and creation of a separate model without downside risk.  

To download the complete report, including a table summarizing the recommendations of the seven organizations for the major financial aspects of the proposed rule, visit MedeAnalytics' ACO Resource Center at www.medeanalytics.com/aco.

About MedeAnalytics

Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit www.medeanalytics.com.

For more information:
Bruce Lewis
Lewis & Summers Public Relations
(707) 813-1197
bruce@prwebsite.com


'/>"/>
SOURCE MedeAnalytics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
2. Unprecedented international meeting releases preliminary vision for our energy future
3. ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow
4. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
5. ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
6. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
7. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
8. OriGene Releases Bioactive Full-length Human MTOR Protein
9. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
10. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
11. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)...  Eli Lilly and Company (NYSE: LLY ... the prevention of migraine at the American Academy of ... 22-28, 2017, in Boston . ... including safety and patient outcomes data for galcanezumab in ... in monthly migraine headache days among patients with episodic ...
(Date:4/20/2017)... ... April 20, 2017 , ... ... scientific and clinical research community’s growing body of knowledge during its Eighth ... Gracie Theatre and the adjacent Darling Atrium. During the event, undergraduates, graduate students, ...
(Date:4/20/2017)... 2017 /PRNewswire/ - Prometic Life Sciences Inc. (TSX: PLI) (OTCQX: PFSCF) ... International Liver Congress ("ILC") 2017 of the European Association for ... on the positive effects of PBI-4050 on reduction ... and metabolic syndrome. ... to Dr. Lyne Gagnon, Vice-President of R&D Pre-clinical of Prometic ...
(Date:4/20/2017)... ... , ... Parallel6™ , the leader in mClinical™ technologies for improving patient ... one of the 2017 Top 10 eClinical Trial Management Solution Providers by Pharma ... “We take pride in honoring Parallel6 as one of the top 10 companies that ...
Breaking Biology Technology:
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based and Touchless), ... published by MarketsandMarkets, the market is expected to be worth USD 18.98 billion ... Continue Reading ... ...      (Logo: ...
(Date:3/22/2017)... YORK , March 21, 2017 ... Marketing Cloud used by retailers such as 1-800-Flowers ... its platform — Product Recommendations and Replenishment. Using Optimove,s ... give more personalized product and replenishment recommendations to ... but also on predictions of customer intent drawn ...
Breaking Biology News(10 mins):